High Fermentation Titer
Removal of feedback inhibition ensures a continuous, fast acid production rate even at high concentrations, solving the low-yield issue.
Valine (Val) is a crucial branched-chain amino acid (BCAA) used extensively as an additive in the animal feed industry and in human nutritional supplements. Industrial production using microbial fermentation, often relying on Corynebacterium glutamicum, is limited by a low acid production rate in fermentation due to strict metabolic regulation and feedback inhibition. Furthermore, the inherent hydrophobicity of the amino acid and the characteristics of the host cell wall often lead to insufficient extraction yield from the fermentation broth, increasing downstream costs. Overcoming these twin challenges is key to making biosynthetic Valine cost-competitive.
CD Biosynsis offers a synthetic biology service focused on engineering Corynebacterium glutamicum for high-titer Valine production. Our core strategy involves modification of valine synthase in Corynebacterium glutamicum . Valine synthesis is tightly regulated by feedback inhibition of Acetolactate Synthase (IlvN/D/E operon), the key enzyme in the BCAA pathway. We focus on modifying the regulatory subunit (IlvN) to create a feedback-resistant variant , ensuring the pathway remains active even at high internal Valine concentrations. This is coupled with optimization of cell membrane permeability . We employ targeted genetic engineering (e.g., modifying genes related to cell wall synthesis or introducing specific transporter proteins like Valine efflux pumps) to enhance the rate of Valine excretion from the cell into the fermentation medium. This dual approach not only boosts the intrinsic production rate (Valine Synthase Modification) but also ensures efficient product release into the broth, mitigating toxicity and significantly improving the overall extraction yield and downstream processing efficiency. This creates a scalable, high-yield, and cost-effective L-Valine manufacturing platform.
Get a QuoteAchieving cost-effective, high-yield Valine production faces these key challenges:
A successful solution must remove metabolic feedback control and actively promote product secretion.
CD Biosynsis utilizes advanced metabolic engineering to optimize Valine production in C. glutamicum:
Modification of Valine Synthase in C. glutamicum
We mutate the regulatory subunit (IlvN) of Acetolactate Synthase to render the enzyme feedback-resistant to Valine and Leucine.
Optimization of Cell Membrane Permeability
We overexpress heterologous or native amino acid efflux pump genes (e.g., BCAA transporters) to actively push Valine out of the cell.
Competing Pathway Blockade
We delete IlvD or IlvC variants that lead to Leucine and Isoleucine synthesis, ensuring maximum carbon flux toward Valine.
Precursor Supply Enhancement
We optimize the upstream Pyruvate dehydrogenase complex and TCA cycle flux to increase the supply of the Pyruvate precursor.
This systematic approach ensures a high internal production rate and highly efficient external secretion, maximizing final yield.
Our Valine engineering service is dedicated to pursuing the following production goals:
High Fermentation Titer
Removal of feedback inhibition ensures a continuous, fast acid production rate even at high concentrations, solving the low-yield issue.
Improved Extraction Yield
Active efflux pumps increase product secretion, reducing downstream purification costs and making the process economically competitive. [Image of Cost Reduction Icon]
L-Valine Purity Guarantee Icon
Biosynthesis ensures the production of the biologically active L-isomer required for feed and food applications.
C. glutamicum GRAS Host Icon
Uses a generally recognized as safe (GRAS) host for safe and regulatory-compliant food/feed production.
Reduced Product Toxicity
Active Valine efflux prevents internal accumulation, improving cell viability and overall productivity.
We provide a sustainable, high-performance, and economically optimized L-Valine manufacturing solution.
Our Valine strain engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and secretion efficiency.
Explore the potential for a high-performance Valine supply. CD Biosynsis provides customized strain and pathway engineering solutions:
Why is Valine production highly regulated in C. glutamicum?
Valine is an essential BCAA. Its synthesis must be tightly controlled by the cell to maintain internal amino acid balance. The primary control point is the Acetolactate Synthase, which is inhibited by the end products Valine and Leucine .
How does optimization of membrane permeability help?
Valine accumulation inside the cell slows production (due to toxicity and feedback). Enhancing membrane permeability via efflux pumps actively removes the product, relieving internal toxicity and feedback pressure , leading to a higher volumetric titer and easier downstream extraction.
Which enzyme modification is critical for removing feedback inhibition?
The modification of the IlvN subunit of Acetolactate Synthase (IlvN}^{mut) is critical. IlvN is the regulatory subunit that detects Valine levels. Mutating it renders the entire enzyme complex permanently active.
Why is Pyruvate supply important?
Pyruvate is the direct precursor for Valine synthesis. Increasing the flux of Pyruvate from glucose metabolism ensures the pathway has all the necessary building blocks to handle the accelerated flux from the feedback-resistant Acetolactate Synthase.
What is the estimated project timeline?
A project involving enzyme mutagenesis, pathway deletion, and efflux pump integration typically requires 22-26 weeks for final strain delivery and comprehensive performance validation.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.